Company Overview of Valcrest Pharmaceuticals, LLC
Valcrest Pharmaceuticals, LLC develops and commercializes pharmaceutical products for ultra-rare orphan diseases. It offers Val-220, a novel oral therapy for the systemic treatment of Mastocytosis. The company was incorporated in 2015 and is headquartered in Mountain View, California.
809-B Cuesta Drive
Mountain View, CA 94040
Founded in 2015
Key Executives for Valcrest Pharmaceuticals, LLC
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Valcrest Pharmaceuticals, LLC, please visit valcrestpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.